CME Group Inc. Reports Highest Q3 Revenue on Record for Q3 2026

Record third-quarter trading volume accompanied higher earnings, while technology and licensing expenses increased year over year.

Rhea-AI Summary

CME Group (NASDAQ: CME) reported its highest third-quarter revenue on record, reaching $1.7 billion in the third quarter of 2026. Revenue totaled $1,737.3 million versus $1,537.6 million a year earlier. Net income rose to $1,036.9 million from $908.0 million, while diluted earnings per share increased to $2.89 from $2.49. Operating income reached $1,141.4 million versus $972.6 million.

Average daily volume reached a third-quarter record of 29.4 million contracts, with double-digit growth across all six asset classes. Market data revenue reached a record $243 million, up 20%. Adjusted diluted earnings per share were $3.02. CME returned $465 million through regular quarterly dividends and $524 million through share repurchases. At September 30, cash, including $225 million deposited with Fixed Income Clearing Corporation, totaled $2.4 billion, against $3.4 billion of debt.

22 points · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 9 points

How the balance works

Positive

• Moderate pointQ3 revenue increased to $1,737.3 million from $1,537.6 million a year earlier.
• Moderate pointQ3 average daily volume reached a third-quarter record of 29.4 million contracts.
• Minor pointQ3 net income rose to $1,036.9 million from $908.0 million a year earlier.
• Minor pointQ3 diluted earnings per share increased to $2.89 from $2.49 a year earlier.
• Minor pointQ3 operating income increased to $1,141.4 million from $972.6 million a year earlier.

17 minor points

• Minor pointVolume across all six asset classes recorded double-digit growth in Q3.
• Minor pointNon-U.S. average daily volume reached a third-quarter high of 9 million contracts.
• Minor pointQ3 clearing and transaction fees increased to $1,378.1 million from $1,227.9 million a year earlier.
• Minor pointQ3 market data revenue reached a record $243 million, up 20%.
• Minor pointQ3 other revenue increased to $116.1 million from $107.2 million a year earlier.
• Minor pointQ3 share repurchases returned $524 million to shareholders.
• Minor pointNine-month revenue increased to $5,323.6 million from $4,871.9 million in the comparable 2025 period.
• Minor pointNine-month net income increased to $3,233.0 million from $2,889.3 million in the comparable 2025 period.
• Minor pointNine-month diluted EPS increased to $8.96 from $7.92 in the comparable 2025 period.
• Minor pointNine-month operating income increased to $3,558.2 million from $3,209.9 million in the comparable 2025 period.
• Minor pointQ3 compensation and benefits decreased to $234.3 million from $237.6 million a year earlier.
• Minor pointQ3 professional fees and outside services decreased to $31.1 million from $36.7 million a year earlier.
• Minor pointQ3 purchased-intangible amortization decreased to $56.0 million from $56.2 million a year earlier.
• Minor pointQ3 borrowing costs decreased to $43.5 million from $44.0 million a year earlier.
• Minor pointQ3 equity earnings from unconsolidated subsidiaries increased to $102.8 million from $96.3 million a year earlier.
• Minor pointQ3 other non-operating expense narrowed to $1,264.0 million from $1,396.6 million a year earlier.
• Minor pointAverage daily capital efficiencies reached a new high of $100 billion.

Negative

• Moderate pointCash and equivalents fell to $2,198.5 million at September 30, 2026, from $4,416.9 million at year-end 2025.
• Minor pointShareholders' equity declined to $26,560.3 million at September 30, 2026, from $28,728.2 million at year-end 2025.
• Minor pointLong-term debt increased to $3,425.1 million at September 30, 2026, from $3,422.3 million at year-end 2025.
• Minor pointQ3 technology expenses increased to $80.9 million from $71.4 million a year earlier.
• Minor pointQ3 licensing and other fee expenses increased to $104.2 million from $81.6 million a year earlier.

4 minor points

• Minor pointQ3 depreciation and amortization increased to $27.4 million from $26.4 million a year earlier.
• Minor pointQ3 other operating expenses increased to $62.0 million from $55.1 million a year earlier.
• Minor pointQ3 investment income decreased to $1,418.1 million from $1,548.7 million a year earlier.
• Minor pointQ3 income tax provision increased to $317.9 million from $269.0 million a year earlier.

News Explained

All 4,584,000 preferred shares had been converted to Class A common stock on March 5, 2026, and their weighted-average effect is included in diluted share counts beginning in the first quarter of 2026, so the conversion is reflected in the common-share ownership base.

Key Figures

Revenue: $1.7 billion Operating income: $1.1 billion Net income: $1.0 billion +5 more

Revenue

$1.7 billion

Q3 2026; highest Q3 revenue on record

Operating income

$1.1 billion

Q3 2026

Net income

$1.0 billion

Q3 2026

Diluted EPS

$2.89

Q3 2026

Adjusted diluted EPS

$3.02

Q3 2026

Average daily volume

29.4 million contracts

Q3 2026; highest Q3 ADV on record

Market data revenue

$243 million; increase of 20%

Q3 2026

Capital returned

Nearly $1 billion

Q3 2026; $465 million in dividends and $524 million in share repurchases

Key Terms

non-gaap, average daily volume, central counterparty

3 terms

non-gaap financial

"Financial results presented on an adjusted basis ... exclude certain items"

Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.

View in glossary

average daily volume financial

"Q3 2026 average daily volume (ADV) climbed to a third-quarter record"

Average daily volume is the typical number of shares or contracts of a security traded each day, calculated by averaging daily trading amounts over a recent period. It matters to investors because it indicates how easy it is to buy or sell without moving the price—like traffic on a road: high volume is a busy freeway that lets many cars pass smoothly, while low volume can make large orders cause big price changes and higher costs.

View in glossary

central counterparty financial

"one of the world's leading central counterparty clearing providers"

A central counterparty is a specialized financial firm that stands between two parties in a trade, becoming the buyer to every seller and the seller to every buyer to ensure transactions settle as agreed. It matters to investors because it reduces the risk that a failed participant will derail trades—acting like an impartial referee and insurance backstop—helping keep markets liquid, orderly and less prone to sudden price swings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

•  Double-digit revenue and net income growth

CHICAGO, Oct. 21, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2026.

The company reported revenue of $1.7 billion and operating income of $1.1 billion for the third quarter of 2026. Net income was $1.0 billion and diluted earnings per common share were $2.89. On an adjusted basis, operating income was $1.2 billion, net income was $1.1 billion and diluted earnings per common share were $3.02. Financial results presented on an adjusted basis for the third quarter of 2026 and 2025 exclude certain items, which are detailed in the reconciliation of non-GAAP results.¹

"As uncertainty intensified in Q3, clients turned to CME Group in record numbers to manage risk and capitalize on opportunities," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Our average daily volume reached 29.4 million contracts, the highest Q3 ADV on record. With double-digit volume growth across all six asset classes, Q3 was our second highest quarter ever for revenue and adjusted net income. We launched several innovative new products and generated a new high of $100 billion in average daily capital efficiencies. We also made strong progress in our cloud migration, making CME Group the only exchange to offer clients the choice of both co-location and cloud-managed services to expand access to our markets for years to come."

Q3 2026 average daily volume (ADV) climbed to a third-quarter record of 29.4 million contracts, and non-U.S. ADV reached a third-quarter high of 9 million contracts.

Clearing and transaction fees revenue for third-quarter 2026 totaled $1.4 billion. The total average rate per contract was $0.679. Market data revenue totaled a record $243 million for third-quarter 2026, an increase of 20%.

1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of Adjusted Operating Income and Adjusted Net Income and Adjusted Earnings per Common Share charts at the end of the financial statements.

As of September 30, 2026, the company had $2.4 billion in cash (including $225 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company returned nearly $1 billion to shareholders during the quarter, with $465 million in regular quarterly dividends and $524 million in share repurchases.

CME Group will hold a Q&A conference call to discuss third-quarter 2026 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs associated with CME Group's transition to the Google Cloud, and minimize duplicative costs of maintaining both on-premise and Google Cloud environments during the transition; the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk from third parties, including risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors, futures commission merchants, introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments, alliances, strategic partnerships and joint ventures; variances in earnings on cash accounts and collateral that our clearing house holds; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2026, under the caption "Risk Factors".

CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
		September 30, 2026		December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents		$                  2,198.5		$                  4,416.9
Marketable securities		131.0		125.0
Accounts receivable, net of allowance		788.1		639.2
Other current assets (includes $3.5 and $6.5 in restricted cash)		840.9		522.1
Performance bonds and guaranty fund contributions		155,179.7		159,656.1
Total current assets		159,138.2		165,359.3
Property, net of accumulated depreciation and amortization		338.7		362.7
Intangible assets—trading products		17,175.3		17,175.3
Intangible assets—other, net		2,440.1		2,610.7
Goodwill		10,505.9		10,514.7
Other assets		2,494.3		2,401.5
Total Assets		$              192,092.5		$              198,424.2
LIABILITIES AND EQUITY
Current Liabilities:
Accounts payable		$                       67.7		$                       71.8
Other current liabilities		865.5		568.8
Performance bonds and guaranty fund contributions		155,179.7		159,656.1
Total current liabilities		156,112.9		160,296.7
Long-term debt		3,425.1		3,422.3
Deferred income tax liabilities, net		5,208.6		5,242.2
Other liabilities		785.6		734.8
Total Liabilities		165,532.2		169,696.0
Total CME Group Shareholders' Equity		26,560.3		28,728.2
Total Liabilities and Equity		$              192,092.5		$              198,424.2

 

CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
				Quarter Ended September 30,								Nine Months Ended September 30,
				2026				2025				2026				2025
Revenues
Clearing and transaction fees				$    1,378.1				$    1,227.9				$   4,273.2				$   3,953.2
Market data and information services				243.1				202.5				705.3				595.1
Other				116.1				107.2				345.1				323.6
Total Revenues				1,737.3				1,537.6				5,323.6				4,871.9
Expenses
Compensation and benefits				234.3				237.6				690.8				665.9
Technology				80.9				71.4				240.8				208.0
Professional fees and outside services				31.1				36.7				88.4				102.6
Amortization of purchased intangibles				56.0				56.2				168.1				167.5
Depreciation and amortization				27.4				26.4				82.8				81.0
Licensing and other fee agreements				104.2				81.6				320.1				274.4
Other				62.0				55.1				174.4				162.6
Total Expenses				595.9				565.0				1,765.4				1,662.0
Operating Income				1,141.4				972.6				3,558.2				3,209.9
Non-Operating Income (Expense)
Investment income				1,418.1				1,548.7				4,237.1				3,959.8
Interest and other borrowing costs				(43.5)				(44.0)				(130.7)				(129.7)
Equity in net earnings of unconsolidated subsidiaries				102.8				96.3				302.9				283.5
Other non-operating income (expense)				(1,264.0)				(1,396.6)				(3,774.1)				(3,571.4)
Total Non-Operating Income (Expense)				213.4				204.4				635.2				542.2
Income before Income Taxes				1,354.8				1,177.0				4,193.4				3,752.1
Income tax provision				317.9				269.0				960.4				862.8
Net Income				$    1,036.9				$       908.0				$   3,233.0				$   2,889.3
Net Income Attributable to Common Shareholders of CME Group - Basic(1)				$    1,036.9				$       896.6				$   3,234.2				$   2,853.0
Net Income Attributable to Common Shareholders of CME Group - Diluted(1)				$    1,036.9				$       896.6				$   3,233.0				$   2,853.0
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic				$         2.90				$         2.49				$        9.00				$        7.93
Diluted				2.89				2.49				8.96				7.92
Weighted Average Number of Common Shares:
Basic				358,019				359,686				359,336				359,653
Diluted(2)				358,641				360,422				361,018				360,330

1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.

2. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.

 

CME Group Inc. and Subsidiaries
Reconciliation of Adjusted Operating Income
(dollars in millions)
			Quarter Ended September 30,									Nine Months Ended September 30,
			2026					2025				2026				2025
Total Revenues			$    1,737.3					$    1,537.6				$  5,323.6				$  4,871.9
Adjusted Total Revenues			$    1,737.3					$    1,537.6				$  5,323.6				$  4,871.9
Total Expenses			$       595.9					$       565.0				$  1,765.4				$  1,662.0
Restructuring and severance			(5.4)					(6.5)				(15.4)				(9.0)
Deferred compensation(1)			0.1					(6.1)				(11.5)				(11.6)
Amortization of purchased intangibles			(56.0)					(56.2)				(168.1)				(167.5)
Strategic transaction-related (costs) credits			(0.7)					(1.2)				(2.3)				(4.0)
Real estate-related (costs) credits			(0.7)					(0.7)				(0.7)				7.4
Foreign exchange transaction gains (losses)			(1.4)					0.8				(0.8)				(5.1)
Unrealized and realized gains (losses) on assets			—					—				—				(0.4)
Litigation matters or settlements			—					(8.5)				(1.9)				(19.4)
Adjusted Total Expenses			$       531.8					$       486.6				$  1,564.7				$  1,452.4
Operating Income			$    1,141.4					$       972.6				$  3,558.2				$  3,209.9
Adjusted Operating Income			$    1,205.5					$    1,051.0				$  3,758.9				$  3,419.5

1. Includes $0.1 million and $11.5 million for changes in our non-qualified deferred compensation liability in the third quarter and first nine months of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income.

 

CME Group Inc. and Subsidiaries
Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share
(dollars in millions, except per share amounts; shares in thousands)
		Quarter Ended September 30,				Nine Months Ended September 30,
		2026		2025		2026		2025
Net Income		$    1,036.9		$       908.0		$  3,233.0		$  2,889.3
Restructuring and severance		5.4		6.5		15.4		9.0
Amortization of purchased intangibles(1)		60.0		69.6		180.1		207.2
Strategic transaction-related costs (credits)(2)		—		3.7		0.4		6.5
Real estate-related costs (credits)		0.7		0.7		0.7		(7.4)
Foreign exchange transaction (gains) losses		1.4		(0.8)		0.8		5.1
Unrealized and realized (gains) losses on investments		0.1		(0.4)		19.1		6.1
Unrealized and realized (gains) losses on assets		—		—		—		0.4
Litigation matters or settlements		—		8.5		1.9		19.4
Income tax effect related to above		(16.3)		(18.2)		(52.6)		(49.8)
Other income tax items		(4.3)		0.8		(13.1)		(8.1)
Adjusted Net Income		$    1,083.9		$       978.4		$  3,385.7		$  3,077.7
Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic(3)		$    1,083.9		$       966.1		$  3,386.4		$  3,039.0
Adjusted Net Income Attributable to Common Shareholders of CME Group - Diluted(3)		$    1,083.9		$       966.1		$  3,385.7		$  3,039.0
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic		$         2.90		$         2.49		$       9.00		$       7.93
Diluted		2.89		2.49		8.96		7.92
Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:
Basic		$         3.03		$         2.69		$       9.42		$       8.45
Diluted		3.02		2.68		9.38		8.43
Weighted Average Number of Common Shares:
Basic		358,019		359,686		359,336		359,653
Diluted(4)		358,641		360,422		361,018		360,330

1. Includes $2.6 million and $7.8 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million and $4.2 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the third quarter and first nine months of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.
2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as that schedule does not include adjustment items or portions of items included in non-operating results.
3. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.
4. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.

 

CME Group Inc. and Subsidiaries
Quarterly Operating Statistics
		3Q 2025		4Q 2025		1Q 2026		2Q 2026		3Q 2026
Trading Days		64		64		61		62		64

 

Quarterly Average Daily Volume (ADV)(1)
CME Group ADV (in thousands)
Product Line		3Q 2025		4Q 2025		1Q 2026		2Q 2026		3Q 2026
Interest rates		13,378		13,010		18,674		14,532		15,121
Equity indexes		6,278		7,738		8,655		8,633		7,714
Foreign exchange		834		853		1,193		989		988
Energy		2,295		2,523		3,985		2,667		2,665
Agricultural commodities		1,712		1,787		2,042		2,080		2,022
Metals		825		1,441		1,682		941		935
Total		25,322		27,353		36,231		29,843		29,445
Venue
CME Globex		23,418		25,542		33,633		27,935		27,472
Open outcry		989		816		1,241		830		872
Privately negotiated		915		995		1,357		1,078		1,100
Total		25,322		27,353		36,231		29,843		29,445

 

Quarterly Average Rate Per Contract (RPC)(1)
CME Group RPC
Product Line		3Q 2025		4Q 2025		1Q 2026		2Q 2026		3Q 2026
Interest rates		$          0.487		$          0.486		$          0.457		$          0.480		$          0.489
Equity indexes		0.652		0.611		0.597		0.605		0.605
Foreign exchange		0.841		0.847		0.780		0.813		0.852
Energy		1.214		1.245		1.084		1.131		1.146
Agricultural commodities		1.423		1.427		1.344		1.426		1.377
Metals		1.505		1.295		1.153		1.315		1.326
Average RPC		$          0.702		$          0.707		$          0.652		$          0.678		$          0.679

1. ADV and RPC includes futures and options on futures only.

CME-G

View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-highest-q3-revenue-on-record-for-q3-2026-302915184.html

SOURCE CME Group

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were CME Group's third-quarter 2026 earnings per share?

CME Group reported diluted earnings per share of $2.89, compared with $2.49 in the third quarter of 2025. Adjusted diluted earnings per share were $3.02, excluding certain items.

How much did CME Group's trading volume reach in Q3 2026?

Average daily volume reached a third-quarter record of 29.4 million contracts. Non-U.S. average daily volume reached a third-quarter high of 9 million contracts, and all six asset classes recorded double-digit volume growth.

What was CME Group's average rate per contract in Q3 2026?

CME Group's total average rate per contract was $0.679 in the third quarter of 2026.